BPC 157 Therapy in Austin BEAUX MedSpa Revolutionizing Recovery: How Dr. Lundquist is Using BPC 157, TB 500, and Regenerative Therapies to Accelerate Healing Active Life Pain Center BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Peptide Therapy for Inflammation: A New Solution Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs